Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Rationale: Heterozygous mutations in the coding regions of the telomerase genes, TERT and TERC, have been found in familial and sporadic cases of idiopathic interstitial pneumonia. All affected patients with mutations have short telomeres. Objectives: To test whether telomere shortening is a frequent mechanism underlying pulmonary fibrosis, we have characterized telomere lengths in subjects with familial or sporadic disease who do not have coding mutations in TERT or TERC. Methods: Using a modified Southern blot assay, the telomerase restriction fragment length method, and a quantitative polymerase chain reaction assay we have measured telomere lengths of genomic DNA isolated from circulating leukocytes from normal control subjects and subjects with pulmonary fibrosis. Measurements and Main Results: All affected patients with telomerase mutations, including case subjects heterozygous for newly reported mutations in TERT, have short telomere lengths. A significantly higher proportion of probands with familial pulmonary fibrosis (24%) and sporadic case subjects (23%) in which no coding mutation in TERT or TERC was found had telomere lengths less than the 10th percentile when compared with control subjects (P = 2.6 × 10−8). Pulmonary fibrosis affectation status was significantly associated with telomerase restriction fragment lengths, even after controlling for age, sex, and ethnicity (P = 6.1 × 10−11). Overall, 25% of sporadic cases and 37% of familial cases of pulmonary fibrosis had telomere lengths less than the 10th percentile. Conclusions: A significant fraction of individuals with pulmonary fibrosis have short telomere lengths that cannot be explained by coding mutations in telomerase. Telomere shortening of circulating leukocytes may be a marker for an increased predisposition toward the development of this age-associated disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Short telomeres are an established risk factor for IPF, and 37% of familial cases and 25% of sporadic cases show telomere lengths below the tenth percentile for their age, as assessed in circulating leukocytes and alveolar epithelial cells54.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The frequency of these mutations is highest in individuals with the progressive disorder IPF, which accounts for 8–15% of familial and 1–3% of sporadic cases54,56,68,69.”
From The telomere syndromes (2012) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487 · cited 2×
“It had been previously shown that a quantitative PCR method for estimating telomere length is fast, inexpensive, and requires significantly less DNA than measurement by Southern blotting (13).”
MethodTelomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Association between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761 · cited 1×
“0096 unit/year, generally consistent with other reports of rates of attrition (14, 25, 26).”
BackgroundObesity, cigarette smoking, and telomere length in women
Valdes, A., Andrew, T., Gardner, J., Kimura, M., Oelsner, E., Cherkas, L., Aviv, A., & Spector, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66630-5 · Cited by 1,363 · cited 1×
“Smoking has been associated with short telomere lengths (27, 28).”
BackgroundTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 4×
“A clue to the genetic underpinnings of the familial subtype of this disorder emerged from the discovery that a subset (z15%) of patients with IPF is heterozygous for mutations in the genes encoding the protein component (TERT) and the RNA component (TERC) of telomerase, a ribonucleoprotein enzyme that catalyzes the ad…”
BackgroundMethodInfluentialIncidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310 · cited 6×
“In epidemiologic studies, IPF is diagnosed more commonly in males than females (1).”
BackgroundMethodSelf-citationHemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894 · cited 22×
“In epidemiologic studies, IPF is diagnosed more commonly in males than females (1).”
BackgroundMethodResultSelf-citationGenetic determination of telomere size in humans: a twin study of three age groups.
Slagboom, P. E., Droog, S., & Boomsma, D. I. (1994) · PubMed Central · Cited by 826
Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.
Baumgartner, K. B., Samet, J. M., Stidley, C. A., Colby, T. V., & Waldron, J. A. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.1.9001319 · Cited by 767 · cited 15×
“In epidemiologic studies, IPF is diagnosed more commonly in males than females (1).”
BackgroundInfluentialMutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042980 · Cited by 723 · cited 4×
“Mutations in TERT are present in up to 4% of individuals with acquired aplastic anemia (8), and yet short telomere lengths are found in 34% of patients with this disease (9).”
BackgroundInfluentialBenetos, A., Okuda, K., Lajemi, M., Kimura, M., Thomas, F., Skurnick, J., Labat, C., Bean, K., & Aviv, A. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.381 · Cited by 620 · cited 1×
“A small differenceinmeanTRFLsbetweenthemen(5.84kb)andwomen (6.03 kb) was found (P 5 0.02), which is consistent with other studies ( 21 , 23).”
ResultInfluentialWhite Cell Telomere Length and Risk of Premature Myocardial Infarction
Brouilette, S., Singh, R. K., Thompson, J. R., Goodall, A. H., & Samani, N. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000067426.96344.32 · Cited by 590
BRENDA, enzyme data and metabolic information
Schomburg, I. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.47 · Cited by 525
The Structure and Function of Telomerase Reverse Transcriptase
Autexier, C., & Lue, N. F. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142412 · Cited by 489
Clinical and Pathologic Features of Familial Interstitial Pneumonia
Steele, M. P., Speer, M. C., Loyd, J. E., Brown, K. K., Herron, A., Slifer, S. H., Burch, L. H., Wahidi, M. M., Phillips, J. A., Sporn, T. A., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1104oc · Cited by 432 · cited 2×
“Smoking is a known risk factor for IPF (32) and for the development of interstitial lung disease in at-risk individuals in kindreds with the familial form of the disease (30, 31).”
BackgroundSavage, S. A., Giri, N., Baerlocher, G. M., Orr, N., Lansdorp, P. M., & Alter, B. P. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.004 · Cited by 414 · cited 1×
“Telomere shortening is a common feature of dyskeratosis congenita and bone marrow failure syndromes, two diseases previously associated with mutations in DKC1, TERT, TERC, or TINF2 (5) (reviewed in Garcia and coworkers [6]).”
BackgroundTelomere length is paternally inherited and is associated with parental lifespan
Njajou, O. T., Cawthon, R. M., Damcott, C. M., Wu, S.-H., Ott, S., Garant, M. J., Blackburn, E. H., Mitchell, B. D., Shuldiner, A. R., & Hsueh, W.-C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702703104 · Cited by 387 · cited 1×
“Telomere length is known to be a heritable trait with parental effects ( 37 ).”
BackgroundTelomere length and possible link to X chromosome
Nawrot, T. S., Staessen, J. A., Gardner, J. P., & Aviv, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15535-9 · Cited by 366 · cited 1×
“02), which is consistent with other studies (21, 23).”
ResultCanela, A., Vera, E., Klatt, P., & Blasco, M. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609367104 · Cited by 335 · cited 1×
“Because ethnicity was previously reported to be associated with telomere length (29), we analyzed white male and female case and control subjects separately and found similar results in these smaller subgroups when using all three methods for assessing telomere length (see Table E2).”
ResultTelomere shortening in smokers with and without COPD
Morlá, M., Busquets, X., Pons, J., Sauleda, J., MacNee, W., & Agustí, A. G. N. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00087005 · Cited by 326
A Major Lung Cancer Susceptibility Locus Maps to Chromosome 6q23–25
Bailey-Wilson, J. E., Amos, C. I., Pinney, S. M., Petersen, G. M., de Andrade, M., Wiest, J. S., Fain, P., Schwartz, A. G., You, M., Franklin, W., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/423857 · Cited by 316 · cited 1×
“Similar results have been found in studies of carriers of a major lung cancer susceptibility locus identified by linkage analysis (33).”
ResultAn essential role for fibronectin extra type III domain A in pulmonary fibrosis
Muro, A. F., Moretti, F. A., Moore, B. B., Yan, M., Atrasz, R. G., Wilke, C. A., Flaherty, K. R., Martinez, F. J., Tsui, J. L., Sheppard, D., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1291oc · Cited by 297 · cited 1×
“The development of pulmonary fibrosis versus bone marrow dysfunction in telomerase mutation carriers may be related to secondary ‘‘hits,’’ such as environmental toxins (cigarette smoking), fibrosis-prone intrinsic host mesenchymal responses to injury (34, 35), or other susceptibilities.”
BackgroundProgressive Telomere Shortening in Aplastic Anemia
Ball, S. E., Gibson, F. M., Rizzo, S., Tooze, J. A., Marsh, J. C. W., & Gordon-Smith, E. C. (1998) · Blood · doi:10.1182/blood.v91.10.3582 · Cited by 290 · cited 1×
“Mutations in TERT are present in up to 4% of individuals with acquired aplastic anemia (8), and yet short telomere lengths are found in 34% of patients with this disease (9).”
BackgroundTelomere Length of Circulating Leukocytes Is Decreased in Patients With Chronic Heart Failure
van der Harst, P., van der Steege, G., de Boer, R. A., Voors, A. A., Hall, A. S., Mulder, M. J., van Gilst, W. H., & van Veldhuisen, D. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.027 · Cited by 281 · cited 1×
“0096 unit/year, generally consistent with other reports of rates of attrition (14, 25, 26).”
BackgroundWaghray, M., Cui, Z., Horowitz, J. C., Subramanian, I. M., Martinez, F. J., Toews, G. B., & Thannickal, V. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2882fje · Cited by 270 · cited 1×
“The development of pulmonary fibrosis versus bone marrow dysfunction in telomerase mutation carriers may be related to secondary ‘‘hits,’’ such as environmental toxins (cigarette smoking), fibrosis-prone intrinsic host mesenchymal responses to injury (34, 35), or other susceptibilities.”
BackgroundMapping of a Major Locus that Determines Telomere Length in Humans
Vasa-Nicotera, M., Brouilette, S., Mangino, M., Thompson, J. R., Braund, P., Clemitson, J.-R., Mason, A., Bodycote, C. L., Raleigh, S. M., Louis, E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/426734 · Cited by 257 · cited 1×
“The quantitative trait of TRFLs has been mapped to various loci in normal subjects (38) or in small families with heart disease (19), but the causative genetic variants within these genomic intervals have not been pinpointed.”
BackgroundAndrew, T., Aviv, A., Falchi, M., Surdulescu, G. L., Gardner, J. P., Lu, X., Kimura, M., Kato, B. S., Valdes, A. M., & Spector, T. D. (2006) · The American Journal of Human Genetics · doi:10.1086/500052 · Cited by 252 · cited 2×
“Twin studies suggest that telomere size, as measured by the TRFL assay, displays a heritability of 36–78% (22, 38).”
BackgroundTelomere length in leukocyte subpopulations of patients with aplastic anemia
Brümmendorf, T. H., Maciejewski, J. P., Mak, J., Young, N. S., & Lansdorp, P. M. (2001) · Blood · doi:10.1182/blood.v97.4.895 · Cited by 233 · cited 1×
“In the patients with aplastic anemia, the severity of disease is directly related to the degree of telomere shortening; moreover, a lack of response to immunosuppressive agents is related to shorter telomere length (10, 11).”
BackgroundVulliamy, T. J., Knight, S. W., Mason, P. J., & Dokal, I. (2001) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2001.0389 · Cited by 227 · cited 1×
“Irrespective of the gene in which a mutation is found, patients with dyskeratosis congenita have short telomeres in their circulating leukocytes (7).”
BackgroundTelomere length and heredity: Indications of paternal inheritance
Nordfjäll, K., Larefalk, Å., Lindgren, P., Holmberg, D., & Roos, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501724102 · Cited by 200 · cited 2×
“0096 unit/year, generally consistent with other reports of rates of attrition (14, 25, 26).”
BackgroundMethodEarly Interstitial Lung Disease in Familial Pulmonary Fibrosis
Rosas, I. O., Ren, P., Avila, N. A., Chow, C. K., Franks, T. J., Travis, W. D., McCoy, J. P., May, R. M., Wu, H.-P., Nguyen, D. M., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-254oc · Cited by 180 · cited 2×
“Smoking is a known risk factor for IPF (32) and for the development of interstitial lung disease in at-risk individuals in kindreds with the familial form of the disease (30, 31).”
BackgroundValdes, A. M., Richards, J. B., Gardner, J. P., Swaminathan, R., Kimura, M., Xiaobin, L., Aviv, A., & Spector, T. D. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0357-5 · Cited by 164
Human diseases of telomerase dysfunction: insights into tissue aging
Garcia, C. K., Wright, W. E., & Shay, J. W. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm644 · Cited by 157 · cited 1×
“Telomere shortening is a common feature of dyskeratosis congenita and bone marrow failure syndromes, two diseases previously associated with mutations in DKC1, TERT, TERC, or TINF2 (5) (reviewed in Garcia and coworkers [6]).”
BackgroundC-Terminal Regions of the Human Telomerase Catalytic Subunit Essential for In Vivo Enzyme Activity
Banik, S. S. R., Guo, C., Smith, A. C., Margolis, S. S., Richardson, D. A., Tirado, C. A., & Counter, C. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6234-6246.2002 · Cited by 109
Racial and Ethnic Disparities in Idiopathic Pulmonary Fibrosis: A UNOS/OPTN Database Analysis
Lederer, D. J., Arcasoy, S. M., Barr, R. G., Wilt, J. S., Bagiella, E., D'Ovidio, F., Sonett, J. R., & Kawut, S. M. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01480.x · Cited by 70 · cited 1×
“The majority of case subjects were male and white (Table 1), reflecting the demographics of this disease (1, 24).”
BackgroundAnalysis of Telomeres and Telomerase
Herbert, B., Shay, J. W., & Wright, W. E. (2003) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb1806s20 · Cited by 64
Telomere length changes in patients with aplastic anaemia
Lee, J., Kook, H., Chung, I., Na, J., Park, M., Hwang, T., Kwak, J., Sohn, S., & Kim, H. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02669.x · Cited by 49 · cited 1×
“In the patients with aplastic anemia, the severity of disease is directly related to the degree of telomere shortening; moreover, a lack of response to immunosuppressive agents is related to shorter telomere length (10, 11).”
Background
Cited by
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citationTravis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,290
Self-citationMechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
“This shortening has been attributed to mutations in the gene encoding telomerase reverse transcriptase (TERT), an enzyme crucial to the maintenance of telomere length in adult stem cells 130–132 .”
Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982
Telomeres and telomerase: three decades of progress
Shay, J. W., & Wright, W. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0099-1 · Cited by 924
Metadata
- Authors
- Cronkhite, J. T., Xing, C., Raghu, G., Chin, K. M., Torres, F., Rosenblatt, R. L., & Kim Garcia, C.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- University of Washington (US)
- Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-01
- Volume
- 178
- Issue
- 7
- Pages
- 729-737
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC2556455
- OpenAlex
- W2145949861
- Cited by
- 573
- References
- 39
- Citations by year
- 2026: 21 · 2025: 42 · 2024: 24 · 2023: 32 · 2022: 36 · 2021: 39 · 2020: 44 · 2019: 30 · 2018: 30 · 2017: 29 · 2016: 21 · 2015: 50 · 2014: 34 · 2013: 34 · 2012: 33
- FWCI
- 22.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Center for Research Resources (K23RR020632)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- telomere shortening, pulmonary fibrosis, familial pulmonary fibrosis, telomerase, TERT mutation, TERC mutations, idiopathic interstitial pneumonia, circulating leukocytes, telomere length, disease susceptibility, genetic susceptibility
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Pedigree, Pulmonary Fibrosis, Regeneration, RNA, Case-Control Studies, Telomere, Telomerase, Genetic Predisposition to Disease, Mutation, Missense
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.